Health Conscious
ADQ combines pharmaceutical businesses to launch Arcera
The holding company consolidates the Abu Dhabi sovereign wealth fund’s healthcare interests in Switzerland, Turkey and Egypt
Arcera’s portfolio will consist of 2,000 branded medicines, addressing illnesses in the areas of neurology, gastroenterology, cardiovascular, pain relief, rheumatology and infection. (Photo: Getty Images)
Share
ADQ has launched a new healthcare holding company named Arcera that consolidates the Abu Dhabi sovereign wealth fund’s pharmaceutical interests in Switzerland, Turkey and Egypt, making it one of the MENA region’s largest life sciences businesses. The new company,...